PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2006 by Therion Biologics Corporation.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Therion Biologics Corporation
Information provided by:
Therion Biologics Corporation
ClinicalTrials.gov Identifier:
NCT00088660
First received: July 30, 2004
Last updated: February 7, 2006
Last verified: February 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |